The Ophthalmology Clinical Trials Unit (CTU) at the University of Wisconsin has been conducting research with human subjects for over 40 years.
While the original mission of this office was to administer research projects related to Age-Related Macular Degeneration (AMD), our roles, responsibilities and areas of expertise have now expanded to include trials related to Diabetic Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Ocular Melanoma, Glaucoma, and Pediatric Ophthalmic Diseases. These trials are designed to evaluate the safety and efficacy of new laser treatments, oral medications, IV medications, intravitreal injections, surgeries, vitamins, minerals and devices in the treatment of ophthalmic diseases.
Clinical trials are a valuable means of providing potential alternative treatments for our patients at the UW, while in many cases participation in an investigational trial is the only option remaining for patients who have exhausted approved treatment options.
Indisputably, our most important role is to guide patients through the treatment of these conditions, offering them not only the most current medical techniques and treatments, but also compassionate and knowledgeable care committed to protecting their safety.